ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO015

Educational Efficacy of Mobile Platform in Improving Patient Understanding of Kidney Disease

Session Information

  • Educational Research
    November 03, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Educational Research

  • 900 Educational Research


  • Cronin, Jamie Elisabeth, University of Colorado Denver School of Medicine, Aurora, Colorado, United States
  • Chen, Chang Huei, University of Colorado Health, Aurora, Colorado, United States
  • Salcedo, Ernesto, University of Colorado Denver School of Medicine, Aurora, Colorado, United States

Chronic kidney disease (CKD) is a leading cause of mortality internationally and has very low rates of treatment compliance. Preventing disease progression and minimizing complications is essential in CKD management. Patients’ active participation in their treatment plan is critical. However, participation may be limited due to the complex nature of the disease and lack of understanding. Educational intervention of any kind has been demonstrated to improve both patient and clinically reported outcomes. We aimed to evaluate the efficacy of a free, concise mobile application in educating CKD patients and in promoting participation in decision-making for their treatment.


The app has eleven sections covering all aspects of chronic kidney disease. Built in pre- and post-surveys utilize a Likert-type psychometric scale where patients indicate their level of agreement with the statement. The same eleven questions are presented in each survey and are designed to determine the efficacy of the app in educating participants on the urinary system, causes of CKD, stages, lifestyle management, comorbidities, complications, and various treatment methods. Participants first interact with the pre-survey, proceed through the modules, then complete the post-survey. The individual questions are compared between the pre- and post-surveys and a single-tail T-test is used to analyze significance (p-value less than or equal 0.05).


Participant recruitment (goal of N =50) and data collection is still ongoing and will conclude by 7/1/2022. Preliminary data has found the app to be significantly effective in helping patients understand the causes of kidney disease (P < 0.05), lab values (P < 0.05), disease management (P < 0.05), and in contributing to patient confidence in discussing their options with a provider (P < 0.05).


Providing a free, easily accessible, concise application on chronic kidney disease significantly improves health literacy in CKD patients and helps them feel more confident in the decision-making process of their treatment plan.